Lenzing's Two-Front Battle: Operational Momentum Meets a Late-August Shareholder Test
Published on 08/08/2026 at 17:43 | Redaktion boerse-global.de
The Austrian fibre maker Lenzing is telling two very different stories at once. One is about a business that is clawing its way back to pricing power after years of chasing volume. The other is about a balance sheet under renovation, with shareholders set to vote on a €300 million capital increase on August 25 — a decision that will shape the company's trajectory for years.
For now, the market is siding with caution. The stock slipped 2.85 percent on Friday to close at €23.85, leaving it nearly 20 percent below its 52-week high and down 4.79 percent over the past month. Over twelve months, the shares have shed 12.48 percent. Yet beneath that lacklustre price action, the second-quarter numbers tell a more constructive story.
Restructuring announcements like this one bring operational change — but they also bring new workplace risks that need documenting. When plants close and roles shift, employers face fresh health-and-safety obligations they may not have planned for. A free toolkit with 41 ready-to-use templates helps you keep risk assessments current through periods of major organisational change. Download the free Risk Assessment Toolkit
Pricing Power Returns, Costs Fall
Lenzing's "Value over Volume" strategy — a deliberate departure from its previous focus on pushing maximum tonnage — is beginning to show results. Fibre selling prices rose 6 percent in the second quarter while volumes and capacity utilisation held steady, suggesting the company is regaining leverage in a market that has been anything but forgiving.
Pulp prices are adding to the momentum. The average price stood at $850 per tonne in the second quarter, and Lenzing expects that to climb to around $900 per tonne in the third. Adjusted operating EBITDA has pushed past the €100 million mark, and the company has already banked €25 million of its planned €120 million cost-saving programme.
The first-half figures, released on Thursday, paint a more nuanced picture. Net profit doubled to €35.6 million from €15.2 million a year earlier — but that jump was driven primarily by foreign exchange effects and an improved financial result rather than operational strength. Revenue slipped to €1.27 billion from €1.34 billion, while EBITDA fell 10.9 percent to €239.2 million. The resulting EBITDA margin of 18.9 percent sits below the company's self-imposed target corridor of 20 to 25 percent.
A Structural Overhaul With a Price Tag
The strategic reset announced in late July — "Grow Nonwovens, Reset Textiles" — is arguably the most significant structural shift in Lenzing's recent history. The company plans to expand its nonwovens business for hygiene applications while reducing textiles' share of revenue from roughly 45 percent to about 30 percent over the medium term. That means winding down fibre production at Heiligenkreuz in Austria by the end of 2026 — the site is now up for sale — and closing the Grimsby plant in England by the end of 2027. Around 2,000 of the company's 7,700 full-time positions are set to disappear.
None of this comes cheap. The refinancing package totals €600 million, comprising the €300 million rights issue and new financing agreements of up to €300 million, alongside an extension of existing liabilities to 2030. The anchor shareholders — B&C Group and Suzano, together holding roughly 52.25 percent of the capital — have already committed €156.7 million. Oberbank, with a 3.86 percent stake, has pledged around €11.6 million. A banking consortium guarantees the remainder. The financing is, in practical terms, largely secured; what remains is the formal approval at the extraordinary general meeting in Lenzing's cultural centre on August 25.
The Dilution Question
The bear case is straightforward: a capital increase of up to €300 million against a current market capitalisation of roughly €907.5 million will meaningfully alter the shareholder structure, even with subscription rights for existing investors. Beyond that, the company faces potential impairment charges of up to €150 million on fixed assets in 2026 — non-cash and without EBITDA impact, but a clear drag on EBIT and group results. Restructuring provisions of up to €40 million will hit this year's EBITDA directly.
There are political complications too. Hans Peter Doskozil, the governor of Burgenland where Heiligenkreuz is located, has not ruled out the state taking over the plant if no private buyer emerges — a sign that the disposal process may not run entirely smoothly. And on the operational side, the question lingers whether the first-half revenue decline signals structural weakness in textiles demand that nonwovens growth cannot fully offset.
What the Chart Says
Technical indicators offer little relief for the bulls. Friday's close of €23.85 sits just 0.77 percent below the 200-day moving average of €24.04 — a level that, if lost, could spook short-term traders. The 50-day average at €24.52 is out of reach for now, and the relative strength index at 47.7 remains neutral, offering no oversold signal for a classic bounce.
The 52-week low of €19.40 provides a cushion of roughly 23 percent, but the market appears to be pricing in the refinancing and capital measures well ahead of the August vote. The tension is hard to miss: improving operations on one side, a share price that has been going nowhere on the other.
The Road Ahead
The August 25 meeting is unlikely to be a referendum on whether Lenzing needs the financing — the backing of anchor shareholders and the bank consortium makes that a near-certainty. What it will decide is the precise shape and terms of the capital increase. Should shareholder approval falter, or should impairments and restructuring costs prove heavier than flagged, the pressure on margins and the share price would intensify.
If the capital increase goes through as planned, Lenzing gains the financial room to execute its restructuring without acute liquidity pressure. The company is targeting a leverage ratio below 2.5x and aims to return to its 20–25 percent EBITDA margin corridor by the end of 2027. The cost programme is on track, pricing power is returning, and the strategic direction is clearer than it has been in years. The question is whether existing shareholders are willing to pay for that clarity — and whether the market will reward them for it once the uncertainty lifts.
